These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 22013483)
1. The inhibitory role of b7-h4 in antitumor immunity: association with cancer progression and survival. He C; Qiao H; Jiang H; Sun X Clin Dev Immunol; 2011; 2011():695834. PubMed ID: 22013483 [TBL] [Abstract][Full Text] [Related]
2. B7-H4 expression by nonhematopoietic cells in the tumor microenvironment promotes antitumor immunity. Rahbar R; Lin A; Ghazarian M; Yau HL; Paramathas S; Lang PA; Schildknecht A; Elford AR; Garcia-Batres C; Martin B; Berman HK; Leong WL; McCready DR; Reedijk M; Done SJ; Miller N; Youngson B; Suh WK; Mak TW; Ohashi PS Cancer Immunol Res; 2015 Feb; 3(2):184-95. PubMed ID: 25527357 [TBL] [Abstract][Full Text] [Related]
3. Potential targeting of B7-H4 for the treatment of cancer. Podojil JR; Miller SD Immunol Rev; 2017 Mar; 276(1):40-51. PubMed ID: 28258701 [TBL] [Abstract][Full Text] [Related]
4. B7-H3 and B7-H4 expression in phyllodes tumors of the breast detected by RNA in situ hybridization and immunohistochemistry: Association with clinicopathological features and T-cell infiltration. Kim GE; Kim NI; Park MH; Lee JS Tumour Biol; 2018 Nov; 40(11):1010428318815032. PubMed ID: 30486739 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance of the B7-H4 coregulatory molecule as a novel prognostic marker in gastric cancer. Arigami T; Uenosono Y; Ishigami S; Hagihara T; Haraguchi N; Natsugoe S World J Surg; 2011 Sep; 35(9):2051-7. PubMed ID: 21748517 [TBL] [Abstract][Full Text] [Related]
6. Could B7-H4 serve as a target to activate anti-cancer immunity? Wang L; Heng X; Lu Y; Cai Z; Yi Q; Che F Int Immunopharmacol; 2016 Sep; 38():97-103. PubMed ID: 27258187 [TBL] [Abstract][Full Text] [Related]
7. A T-cell-engaging B7-H4/CD3-bispecific Fab-scFv Antibody Targets Human Breast Cancer. Iizuka A; Nonomura C; Ashizawa T; Kondou R; Ohshima K; Sugino T; Mitsuya K; Hayashi N; Nakasu Y; Maruyama K; Yamaguchi K; Akiyama Y Clin Cancer Res; 2019 May; 25(9):2925-2934. PubMed ID: 30737243 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma. Xie N; Cai JB; Zhang L; Zhang PF; Shen YH; Yang X; Lu JC; Gao DM; Kang Q; Liu LX; Zhang C; Huang XY; Zou H; Zhang XY; Song ZJ; Sun HX; Fu BM; Ke AW; Shi GM Cell Death Dis; 2017 Dec; 8(12):3205. PubMed ID: 29235470 [TBL] [Abstract][Full Text] [Related]
9. Assessment of combined expression of B7-H3 and B7-H4 as prognostic marker in esophageal cancer patients. Chen L; Xie Q; Wang Z; Shi L; Wu C; Jiang J Oncotarget; 2016 Nov; 7(47):77237-77243. PubMed ID: 27764786 [TBL] [Abstract][Full Text] [Related]
10. Induced expression of B7-H4 on the surface of lung cancer cell by the tumor-associated macrophages: a potential mechanism of immune escape. Chen C; Qu QX; Shen Y; Mu CY; Zhu YB; Zhang XG; Huang JA Cancer Lett; 2012 Apr; 317(1):99-105. PubMed ID: 22108530 [TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of B7-H4 correlates with poor prognosis and suppresses tumor-infiltration of CD8+ T lymphocytes in human cholangiocarcinoma. Zhao X; Guo F; Li Z; Jiang P; Deng X; Tian F; Li X; Wang S Oncol Rep; 2016 Jul; 36(1):419-27. PubMed ID: 27177355 [TBL] [Abstract][Full Text] [Related]
12. Elevated expression of B7 homolog 4 is associated with disease progression in upper urinary tract urothelial carcinoma. Mizuno T; Kamai T; Tsuzuki T; Nishihara D; Kijima T; Arai K; Yoshida KI Cancer Immunol Immunother; 2022 Mar; 71(3):565-578. PubMed ID: 34275008 [TBL] [Abstract][Full Text] [Related]
13. Association of increased B7 protein expression by infiltrating immune cells with progression of gastric carcinogenesis. Guo L; Liu Z; Zhang Y; Quan Q; Huang L; Xu Y; Cao L; Zhang X Medicine (Baltimore); 2019 Feb; 98(8):e14663. PubMed ID: 30813210 [TBL] [Abstract][Full Text] [Related]
14. Dehydroepiandrosterone attenuated the immune escape of oral squamous cell carcinoma through NF-κB p65/miR-15b-5p/B7-H4 axis. Wang Y; Li R; Yuan R; Wang L; Qiao Q; Han Z; Li Q; Li Y; Guo Y; Guo C Int Immunopharmacol; 2024 Aug; 137():112480. PubMed ID: 38885603 [TBL] [Abstract][Full Text] [Related]
15. T-cell infiltration and expressions of T lymphocyte co-inhibitory B7-H1 and B7-H4 molecules among colorectal cancer patients in northeast China's Heilongjiang province. Liang M; Li J; Wang D; Li S; Sun Y; Sun T; Zhang J; Chen X; Li Q; Sun S Tumour Biol; 2014 Jan; 35(1):55-60. PubMed ID: 23873101 [TBL] [Abstract][Full Text] [Related]
16. Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC). Carvajal-Hausdorf D; Altan M; Velcheti V; Gettinger SN; Herbst RS; Rimm DL; Schalper KA J Immunother Cancer; 2019 Mar; 7(1):65. PubMed ID: 30850021 [TBL] [Abstract][Full Text] [Related]
17. B7-H4, a promising target for immunotherapy. Wang JY; Wang WP Cell Immunol; 2020 Jan; 347():104008. PubMed ID: 31733822 [TBL] [Abstract][Full Text] [Related]
18. Novel recombinant human b7-h4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responses. Dangaj D; Lanitis E; Zhao A; Joshi S; Cheng Y; Sandaltzopoulos R; Ra HJ; Danet-Desnoyers G; Powell DJ; Scholler N Cancer Res; 2013 Aug; 73(15):4820-9. PubMed ID: 23722540 [TBL] [Abstract][Full Text] [Related]
19. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas. Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402 [TBL] [Abstract][Full Text] [Related]
20. Impact of neoadjuvant chemotherapy on lymphocytes and co-inhibitory B7-H4 molecule in gastric cancer: low B7-H4 expression associates with favorable prognosis. Maskey N; Li K; Hu M; Xu Z; Peng C; Yu F; Cao H; Chen J; Li Y; Yang G Tumour Biol; 2014 Dec; 35(12):11837-43. PubMed ID: 25260881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]